Novel Jet-Injection Technology for Nonviral Intratumoral Gene Transfer in Patients with Melanoma and Breast Cancer

Purpose: This phase I clinical trial evaluated safety, feasibility, and efficiency of nonviral intratumoral jet-injection gene transfer in patients with skin metastases from melanoma and breast cancer. Experimental Design: Seventeen patients were enrolled. The patients received five jet injections with a total dose of 0.05 mg β-galactosidase (LacZ)-expressing plasmid DNA (pCMVβ) into a single cutaneous lesion. Clinical and laboratory safety monitoring were done. Systemic plasmid clearance was monitored by quantitative real-time PCR of blood samples throughout the study. All lesions were resected after 2 to 6 days. Intratumoral plasmid DNA load, DNA distribution, and LacZ expression was analyzed by quantitative real-time PCR, quantitative reverse transcription-PCR, Western blot, immunohistochemistry, and 5-bromo-4-chloro-3-indolyl-β-d-galactoside staining. Results: Jet injection of plasmid DNA was safely done in all patients. No serious side effects were observed. Thirty minutes after jet injection, peak plasmid DNA levels were detected in the blood followed by rapid decline and clearance. Plasmid DNA and LacZ mRNA and protein expression were detected in all treated lesions. Quantitative analysis revealed a correlation of plasmid DNA load and LacZ-mRNA expression confirmed by Western blot. Immunohistochemistry and 5-bromo-4-chloro-3-indolyl-β-d-galactoside staining showed LacZ-protein throughout the tumor. Transfected tumor areas were found close and distant to the jet-injection site with varying levels of DNA load and transgene expression. Conclusion: Intratumoral jet injection of plasmid DNA led to efficient LacZ reporter gene expression in all patients. No side effects were experienced, supporting safety and applicability of this novel nonviral approach. A next step with a therapeutic gene product should determine antitumor efficacy of jet-injection gene transfer.

[1]  M. Gottesman.  Cancer gene therapy: an awkward adolescence , 2003, Cancer Gene Therapy.

[2]  Dexi Liu,et al.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.

[3]  Feng Liu,et al.  Development of non-viral vectors for systemic gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[4]  P. Furth,et al.  Gene transfer by jet injection into differentiated tissues of living animals and in organ culture , 1995, Molecular biotechnology.

[5]  D. M. Carlson,et al.  Gene expression following direct injection of DNA into liver. , 1994, Human gene therapy.

[6]  E. Unger,et al.  DNA delivery to cells in vivo by ultrasound. , 2004, Methods in molecular biology.

[7]  I. Fichtner,et al.  Uptake, biodistribution, and time course of naked plasmid DNA trafficking after intratumoral in vivo jet injection. , 2006, Human gene therapy.

[8]  P. Schlag,et al.  Stability analysis for long-term storage of naked DNA: impact on nonviral in vivo gene transfer. , 2003, Analytical biochemistry.

[9]  B. O’Malley,et al.  In vivo gene transfer into rabbit thyroid follicular cells by direct DNA injection. , 1994, Human gene therapy.

[10]  P. Schlag,et al.  Nonviral jet-injection gene transfer for efficient in vivo cytosine deaminase suicide gene therapy of colon carcinoma. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  I. Fichtner,et al.  Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology , 2001, Gene Therapy.

[12]  D. Wells,et al.  Gene Therapy Progress and Prospects: Electroporation and other physical methods , 2004, Gene Therapy.

[13]  Susan M. Chang,et al.  Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Samir Mitragotri,et al.  Needle-free jet injections: dependence of jet penetration and dispersion in the skin on jet power. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[15]  T. Niidome,et al.  Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.

[16]  K. Tamai,et al.  In vivo gene introduction into keratinocytes using jet injection , 1999, Gene Therapy.

[17]  J. Spivak.  The anaemia of cancer: death by a thousand cuts , 2005, Nature Reviews Cancer.

[18]  Samir Mitragotri,et al.  Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets , 2007, Proceedings of the National Academy of Sciences.

[19]  M. Bureau,et al.  Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. , 2004, Biochimica et biophysica acta.

[20]  P. Furth,et al.  Low-volume jet injection for intradermal immunization in rabbits , 2002, BMC biotechnology.

[21]  M. Aoki,et al.  Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease , 2004, Hypertension.

[22]  M J Jaroszeski,et al.  Theory and in vivo application of electroporative gene delivery. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  R. Levy,et al.  Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. , 2002, Cancer research.

[24]  Samir Mitragotri,et al.  Current status and future prospects of needle-free liquid jet injectors , 2006, Nature Reviews Drug Discovery.

[25]  Hanns Lochmüller,et al.  The spread of transgene expression at the site of gene construct injection , 2001, Muscle & nerve.

[26]  P. Schlag,et al.  Local Gene Therapy for Cancer , 2007 .

[27]  P. Schlag,et al.  Heat-inducible in vivo gene therapy of colon carcinoma by human mdr1 promoter–regulated tumor necrosis factor-α expression , 2007, Molecular Cancer Therapeutics.

[28]  S. Hirschfeld,et al.  Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  S. Lippman,et al.  Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[31]  Leaf Huang,et al.  Nonviral gene therapy: promises and challenges , 2000, Gene Therapy.

[32]  Oliver A. Shergold,et al.  The penetration of a soft solid by a liquid jet, with application to the administration of a needle-free injection. , 2006, Journal of biomechanics.

[33]  Karin Pike-Overzet,et al.  New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  Jo Wixon,et al.  Gene therapy clinical trials worldwide to 2007—an update , 2007, The journal of gene medicine.

[35]  N. Yang,et al.  In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Schleef,et al.  Plasmid DNA for pharmaceutical applications. , 2000, Developments in biologicals.

[37]  N. Yang,et al.  Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Stolz,et al.  Hydroporation as the mechanism of hydrodynamic delivery , 2004, Gene Therapy.

[39]  H. Herweijer,et al.  Progress and prospects: naked DNA gene transfer and therapy , 2003, Gene Therapy.

[40]  M. Schleef,et al.  Animal‐free production of ccc‐supercoiled plasmids for research and clinical applications , 2004, The journal of gene medicine.

[41]  R. Dummer,et al.  Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. , 2005, Human gene therapy.

[42]  M. Schuler,et al.  Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  D. Coppola,et al.  Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect , 2002, Gene Therapy.